ArticleJournal of medical cases2025
Ocular Syphilis in an Immunocompetent Patient: Through the Lens.
Article in Journal of medical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular manifestations of syphilis can occur at any stage of the disease and present with a wide range of clinical features. If left untreated, they carry a high risk of permanent vision loss. Although syphilis mainly affects individuals with human immunodeficiency virus (HIV) positive and other immunocompromised individuals, it can also present in immunocompetent individuals. A 61-year-old immunocompetent male presented with blurry vision and associated central vision loss in the left eye. Initial ophthalmologic evaluation revealed bilateral optic-disc swelling and serological tests positive for syphilis, with rapid plasma reagin (RPR) of 1:128 and positive immunoglobulin (Ig)G/IgM, confirming ocular syphilis. The patient was started on intravenous (IV) penicillin G for 14 days and required a prolonged course along with oral steroids due to persistent syphilitic uveitis. This case report highlights the importance of maintaining a low threshold for syphilis screening in patients with unexplained vision loss, regardless of their HIV status. Timely diagnosis and intervention are critical to avoid misdiagnosis and prevent irreversible visual sequelae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.